Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2020-09-18

New oral treatment for moderate to severe atopic dermatitis

View source ↗

Summary

The EMA announces a new oral treatment for adults with moderate to severe atopic dermatitis, representing a new therapeutic option for this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications